MedPath
TGA Approval

BESIVANCE besifloxacin 0.6% w/v suspension eye drops bottle (201509)

201509

BESIVANCE besifloxacin 0.6% w/v suspension eye drops bottle

Bausch & Lomb Australia Pty Ltd

November 7, 2013

Medicine

Medicine

Active

Registered

Active Ingredients

besifloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.